Eligo Bioscience
Pre-clinicalEligo Bioscience is deploying in vivo gene editing technologies against microbiome targets to address diseases with high unmet needs.
Founded
2014
Focus
Drug DeliveryMicrobiomeNanotechnology
About
Eligo Bioscience is deploying in vivo gene editing technologies against microbiome targets to address diseases with high unmet needs.
Company Info
TypePrivate
Founded2014
LocationParis, France
StagePre-clinical
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile